About
Diagnostic Reagents, DNA synthesis, RNA Services
Areas of Focus
Categories
DiagnosticsContract ManufacturingContract ManufacturingChina
Clinical Trials (13)
View allTotal Trials
13
As Lead Sponsor
8
As Collaborator
5
Total Enrollment
17,805
By Phase
PHASE3: 4PHASE2: 3PHASE2/PHASE3: 1PHASE1: 4NA: 1
By Status
COMPLETED: 6UNKNOWN: 3ACTIVE_NOT_RECRUITING: 2TERMINATED: 2
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06207175Lead Sponsor
A Study to Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine
PHASE3Active, not recruiting
1,260 participants
Started: Nov 21, 2023 · Completed: Jan 25, 2026
NCT05811442Lead Sponsor
Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease
PHASE2Completed
68 participants
Started: Apr 18, 2023 · Completed: Sep 11, 2025
NCT05662020Lead Sponsor
A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China
PHASE3Active, not recruiting
2,750 participants
Started: Mar 23, 2022 · Completed: Mar 23, 2028
NCT05668572Lead Sponsor
A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine
PHASE3Unknown
12,000 participants
Started: Dec 5, 2020 · Completed: Feb 23, 2023
NCT04449588Collaborator
Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS
PHASE2/PHASE3Terminated
369 participants
Started: Jul 23, 2020 · Completed: Mar 26, 2024
Locations (1)
Headquarters
Beijing, China
Map
Loading map...